Description
IkarugamycinisanantibioticinitiallyproducedbyspeciesofStreptomycesthatexhibitsantibacterial,anti-protozoal,andanticanceractivities.Ikarugamycinpreventsformationofthebacterial70Sribosomalsubunit,inhibitingproteintranslation.Invitro,ikarugamycininhibitsCCP-dependentphagocytosis,preventingPMA-induceddownregulationofCD4.Additionally,ikarugamycininhibitsuptakeofoxidizedLDL,preventingaccumulationofcholesterolesterinmacrophages.
References
PopescuR,HeissEH,FerkF,etal.IkarugamycininducesDNAdamage,intracellularcalciumincrease,p38MAPkinaseactivationandapoptosisinHL-60humanpromyelocyticleukemiacells.MutatRes.2011May10;709-710:60-6.PMID:21392513.
LuoT,FredericksenBL,HasumiK,etal.Humanimmunodeficiencyvirustype1Nef-inducedCD4cellsurfacedownregulationisinhibitedbyikarugamycin.JVirol.2001Mar;75(5):2488-92.PMID:11160755.
HasumiK,ShinoharaC,NaganumaS,etal.Inhibitionoftheuptakeofoxidizedlow-densitylipoproteininmacrophageJ774bytheantibioticikarugamycin.EurJBiochem.1992Apr15;205(2):841-6.PMID:1572375.
JomonK,KurodaY,AjisakaM,etal.Anewantibiotic,ikarugamycin.JAntibiot(Tokyo).1972May;25(5):271-80.PMID:4625358.